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Background: Pre-hypertension is associated with an increased risk of the development of hypertension and
subsequent cardiovascular disease and raises mortality risk. The aim of this study was to determine the prevalence
of pre-hypertension and to explore the associations between pre-hypertension and established cardiovascular risk
factors in a population-based sample of Iranian adults.
Methods: In this cross-sectional study a representative sample of 892 participants aged ≥30 years was selected
using a multistage cluster sampling method. After completion of a detailed demographic and medical
questionnaire (gender, age, history of diabetes mellitus and hypertension, taking antihypertensive or hypoglycemic
agents and history of smoking), all participants were subjected to physical examination, blood lipid profile, blood
glucose, anthropometric and smoking assessments, during the years 2009 and 2010. Variables were considered
significant at a p-value≤ 0.05. Statistical analysis was performed using SPSS version 11.5 software.
Results: Pre-hypertension was observed among 300 (33.7%) subjects, 36.4% for men and 31.4% for women
(p> 0.05). The pre-hypertensive group had higher levels of blood glucose and triglycerides, higher body mass index
and lower percentage of smoking than did the normotensive group. Multivariate logistic regression analysis
showed that obesity and overweight were the strongest predictors of pre-hypertension [odds ratio, 2.74: 95% CI
(Confidence Interval), 1.62 to 4.62 p< 0.001; odds ratio, 2.56, 95% CI, 1.74 to 3.77, p< 0.001 respectively].
Conclusions: Overweight and obesity are major determinants of the high prevalence rate of pre-hypertension
detected in Iranian population. Therefore, primary prevention strategies should concentrate on reducing overweight
and obesity if the increased prevalence of pre-hypertension is to be diminished in Iranian adults.
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High blood pressure is an important subject in primary
care in the 21st century and has become growing world-
wide, especially in developing countries [1]. Further-
more, hypertension is one of the most important health
problems because of its relation to ischemic heart dis-
ease, which is the leading cause of death [2]. The preva-
lence of hypertension is 8-14% in population, worldwide
[3]. In Iran, the Iranian Health Profile Survey (IHPS) of
1999 reported a hypertension prevalence of 12.54% in* Correspondence: Shojaie1300@yahoo.com
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distribution, and reproduction in any mediumadults older than 30 years [4]. High blood pressure and its
complications is a significant problem and cardiovascular
diseases are the most common cause of death in Iran [5].
Many of studies on different populations have identified
certain factors such as older age, hypercholesterolemia,
diabetes mellitus and increased body mass as being asso-
ciated with high blood pressure [2,6,7]. The last years,
some researchers have documented an increase in the risk
of cardiovascular disease in subjects with systolic blood
pressures (SBP) between 120 – 139 mmHg and/or dia-
stolic blood pressures (DBP) between 80 – 89 mmHg
[8,9]. Based on this current evidence, the Seventh Report
of the Joint National Committee (JNC7) on Prevention,
Detection, Evaluation and Treatment of High Blooded Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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pressure level under the term pre-hypertension [6].
Pre-hypertension is associated with an increased risk
of the development of hypertension and subsequent car-
diovascular disease and raises mortality risk [10-13].
There are additional reports of prevalence percentages
for pre-hypertension, with estimates ranging from 30 –
48.9% [6,7].
The aim of the present study was to estimate the
prevalence of pre-hypertension and to examine its asso-
ciation with established cardiovascular risk factors
(i.e. overweight, obesity, hypercholesterolemia, diabetes
mellitus and smoking) from a population-based study of
Iranian adults, in order to propose primary preventive
strategies for combating it.
Methods
Study participants
The present investigation adopted a cross-sectional
design protocol. The population studied - a multi-stage
stratified clustering sample – was derived from a patient
cohort from ten urban health centers operating in
Jahrom City in the South region of Iran. Pregnant
and lactating women and/or persons with chronic dis-
ease and mental disorders and unable to walk, were
excluded. The final sample consisted of 405 males (aged
51.9 ± 13.9 years) and 487 females (aged 48.5 ± 12.9 years).
All subjects (892) answered a demographic and a
detailed medical questionnaire.
Afterwards, they were subjected to anthropometric,
blood pressure and fasting blood glucose and lipid pro-
file measurements. All data were collected during the
years 2008 and 2009.
Identical standard protocols were used for each meas-
urement conducted by trained physician. Signed
informed sanction was obtained from all participants
and Ethical approval was obtained from the Ethics Com-
mittee of the Jahrom University.
Instruments and measurements
Demographic and medical questionnaire
This includes the demographic and medical records of
patients about “gender, age, history of diabetes mellitus
and hypertension, taking antihypertensive or hypogly-
cemic agents.
Smoking status assessment
Smoking status was ascertained by means of a question-
naire. Subjects, who smoked one or more cigarettes or one
cup of water pipe per week, were considered as smokers.
Anthropometry
Body weight was measured (Seca 700, Germany) to the
nearest 100 grams, with light cloth and without shoes.Height was measured to the nearest 0.5 cm, without
shoes using a stadiometer (Seca 700, Germany). Body
mass index (BMI) was calculated as weight (in kilograms)
divided by height (in meters) squared.
Blood pressure
Blood pressure was measured after the subject had
rested for at least 5 minutes and from right arm placed
at the heart level by a physician. Two measurements
were taken by a mercury sphygmomanometer (Richter,
Germany) with at least 5 minutes between successive
measurements. The mean of two measurements of Kor-
otkoff phase I was recorded for systolic blood pressure
(SBP). The mean of two values of Korotkoff phase IV
was recorded for diastolic blood pressure (DBP). Pre-
hypertension was defined as having either a SBP of 120
to 139 mmHg and/or DBP of 80 to 89 mmHg, according
to JNC7, in persons who were not on antihypertensive
medication [14]. Hypertension was defined as an average
SBP ≥140 mmHg, an average DBP ≥ 90 mmHg, and/or
self reported current treatment for hypertension with
antihypertensive medication.
Serum assessments
Venous blood was collected in the morning after an
overnight fast and serum was used for the biochemical
tests. Diabetes mellitus was defined as having two fasting
serum glucose assessment of equal to or more than
126 mg/dl or being on treatment for diabetes [15]. Dysli-
pidemia was defined according to ATP III report [16].
Hypercholesterolemia was defined as fasting total serum
cholesterol of greater than or equal to 240 mg/dl.
Blood concentration of LDL-C (low-density lipoprotein
cholesterol) equal or above 160 mg/dl and blood con-
centration of HDL-C (high-density lipoprotein choles-
terol) under 40 mg/dl respectively, were considered to
be undesirable.
Statistical analysis
For statistical analysis the BMI (kg/m2) was classified
into two categories: overweight: 25–29.9 and obese:
≥30.0. Continuous variables were presented as mean
values and standard deviation. Categorical variables were
presented as frequencies. Associations between categor-
ical variables were tested by the use of contingency
tables and the chi-square test. Independent T-test was
used to comparisons between continuous variables
and blood groups (hypertension or pre-hypertension
with normal blood pressure). Binary logistic regression
was used to assess the association of age, gender, smok-
ing and anthropometric and serum parameters to blood
pressure (pre-hypertension or normal) by estimating
the odds ratio with 95% confidence interval (CI). Vari-
ables were considered significant at a p-value ≤ 0.05.
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11.5 software.
Results
Characteristics of study participants
A high percentage prevalence of pre-hypertension was
observed in the studied population, 33.7% (95% confi-
dence interval [CI]; 30.6%-36.8%). Pre-hypertension was
higher in men than in women (36.4%; CI, 31.7%-41/1%
and 31.4%; CI, 27.3%-35.5%) but there was no significant
difference in the percentages (p> 0.05). The prevalence
rate of hypertension among all subjects was 35.4%. How-
ever, no significant difference was found in the percen-
tages of the prevalence rate of hypertension in male
(35.1%) and female (35.5%) participants (p> 0.05).
Figure 1 illustrates an age-group specific pattern con-
cerning the pre-hypertension prevalence rate. A steady
decline in the prevalence of pre-hypertension is apparent
with an exception for the 50–59 age group (p = 0.025).
In Table 1 are presented the epidemiological character-
istics of the study participants as blood pressure groups.
It appears that fasting serum glucose, triglyceride and
BMI mean values were higher in pre-hypertensive group
than in the normotensive group, respectively (p = 0.013;
p = 0.002; p< 0.001).
In Table 2 we can observe that the pre-hypertensive
group exhibited higher prevalence of overweight (p <
0.001) and its subjects had 1.77 times increased prob-
ability of being overweight than their normotensive
counterparts. Furthermore the preh-ypertensive group
had higher prevalence of diabetes mellitus, total hyper-
cholesterolemia, and obesity but there was no statistical
difference in percentages (p> 0.05). In addition, fewer
pre-hypertensive subjects reported smoking than their
normotensive counterparts (12.3% vs 18.8%; p = 0.031).
In Table 3 appear the percentages of subjects exhibit-































Figure 1 Prevalence of pre-hypertension by age groups.factors according to their blood pressure indices. 7.6%
and 7.2% of the normotensive group and 16.3% and 9.3%
of the pre-hypertensive group exhibited three and ≥4
additional cardiovascular risk factors, respectively. The
corresponding percentages for the hypertensive group
were 23.5% and 17.4%, respectively.Multivariate logistic regression
In Table 4 the results of multivariate logistic regression
analysis showed that obesity and overweight were the
most powerful predictors of pre-hypertension, with an
odds ratio (OR) of 2.74 (95% CI, 1.62 to 4.62, p< 0.001)
and 2.56 (95% CI, 1.74 to 3.77, p< 0.001), followed by
male gender (OR, 1.89; 95% CI, 1.29 to 2.81, p = 0.002).
On the contrary, age (p = 0.002) and smoking (p = 0.003)
had an inverse effect on pre-hypertension.Discussion
Over the last years increased pre-hypertension rates have
been observed and well documented worldwide. How-
ever, this area is still not fully investigated. Therefore,
the purpose of this study was to further explore this
issue focusing on a population-based sample of adults in
south Iran.
The results revealed that nearly one third of our popu-
lation was classified as pre-hypertensive. A higher per-
centage of the male population - compared to the
female population – was found to exhibit pre-
hypertension, without, however, significant difference in
the percentages. Furthermore, it was also found that
obesity and overweight had the strongest association
with pre-hypertension but, surprisingly, age and smoking
had an inverse effect on pre-hypertension. In addition, it
was disclosed that subjects with pre-hypertension had
multiple additional cardiovascular risk factors when
compared to those with normal blood pressure.
Nontheless, the prevalence of pre-hypertension in the
present study (33.7%) was higher when compared with
the prevalence estimates reported in Jamaica (31%), in
Turkey (14.5%), in Canada (22.0%), in Nigeria (24.8%), in
Tailand (32.8%) and in Japan (33.0%). On the contrary,
the prehypertension estimate in our sample was lower
when compared with the results reported from Taiwan
(35.8%), U.S.A. (36.3%) and China (38.4% and 44.1%)
[6,7,13,17-23]. However, the present findings contradict
the Jamaica Study’s gender specific pattern whereby men
(35.0%) rather than women (25.0%) exhibited higher per-
centages of pre-hypertension [6].
Additionally, it was detected that the prevalence of
prehypertension was higher among younger age groups.
This finding is in line with the published data from
China [7] and Japan [24], but contradicts the results
reported in Iran [25] and Nigeria [18] showing an
Table 1 Subjects characteristics by blood pressure group. Figures are Mean (±SD)
Variable Normotension pre-hypertension p* hypertension p**
Age (years) 43.8 ± 10.0 48.1 ± 12.8 <0.001 57.1 ± 13.4< 0.001 <0.001
Glucose# 88.9 ± 27.1 94.8 ± 29.5 0.013 109.4 ± 50.7 <0.001
Cholesterol# 184.9 ± 41.2 188.7 ± 37.9 0.225 199.0 ± 44.5 <0.001
LDL cholesterol# 112.7 ± 28.6 113.6 ± 30.1 0.704 119.8 ± 35.6 0.008
HDL cholesterol# 47.4 ± 10.8 47.5 ± 10.3 0.851 48.5 ± 10.5 0.195
Triglyceride# 121.9 ± 73.2 144.7 ± 98.6 0.002 155.9 ± 88.8 <0.001
BMI, kg/m2 25.3 ± 4.3 26.8 ± 4.3 <0.001 26.9 ± 4.4 <0.001
* Pre-hypertensive to normotensive subjects comparisons.
** Hypertension to normotensive subjects comparisons.
# mg/dl.
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60 years old.
The present study also complements previous reports
from Iran demonstrating high prevalence of pre-
hypertension. Indeed, results from the Nationwide
Survey in Iran between 2004–2005 revealed a high inci-
dence of pre-hypertension in both sexes aged 25–65, i.e.,
59.6% in men and 44.5% in women, respectively [25].
Similar results were also reported by Sahebi et al. [26]
where 37.2% of hospital staff in Shiraz, Iran, aged
19 years and over, found to be pre-hypertensive.
However, social and cultural differences, the subject’s
characteristics, the age span as well as the methodology
used, may account for the observed discrepancies among
the previous mentioned studies. Nonetheless, although
direct comparisons with other studies are not possible,
it is rather self-evident that the prevalence of pre-
hypertension is high in both developed and developing
countries and in eastern and western populations and,
therefore, needs further in depth clarification.
Another main finding revealed that pre-hypertension
was associated with an increased prevalence of other
cardiovascular risk factors such as age, sex, overweightTable 2 Prevalence of individual cardiovascular risk factors (%
Variable normal pre-HTN
Sex (male,%) 41.7 49.0
Smoking 18.8 12.3
Diabetes mellitus 4.7 8.7
Total 7.6 10.0
Hypercholesterolemia
High LDL level 5.4 6.3




HTN indicates hypertension; RR, risk ratio.
* Ratio of pre-hypertension group to normotensive group.
# Ratio of hypertension group to normotensive group.and obesity. The association of pre-hypertension with mul-
tiple risk factors for cardiovascular disease has been
described in the Jamaican population [6]. Indeed, the
prevalence of hypercholesterolemia, diabetes mellitus,
overweight and obesity was found to be greater among per-
sons with pre-hypertension compared to persons who were
normotensive in Jamaican population [6]. A number of
other studies suggested that persons with pre-hypertension
were more likely to have a higher BMI, total cholesterol,
triglyceride, higher LDL cholesterol and lower HDL choles-
terol level of blood, impaired glucose tolerance, obesity
and older age than persons who had normal blood pres-
sure [3,17,18,27]. This clustering of cardiovascular disease
risk factors among persons with pre-hypertension suggest
the importance of screening for other cardiovascular risk
factors in persons who are classified as pre-hypertensive.
Our results confirmed that obesity and overweight
are major determinants of pre-hypertension. Similar find-
ings were also found in the Chinese survey, in Japan and
in a rural Taiwanese adult population [7,20,24,28-31].
Additionally, in Sahebi et al. [26] study, the association
between pre-hypertension with obesity and overweight
was, also, confirmed.) by blood pressure group
RR* (95% CI) HTN RR# (95% CI)
1.34 (0.97-1.87) 45.1 1.15 (0.83-1.59)
0.6 (0.38-0.96) 8.6 0.40 (0.24-0.66)
1.92 (0.97-3.81) 20.6 5.26 (2.83-9.78)
1.35 (0.75-2.42) 16.5 2.40 (1.40-4.10)
1.18 (0.58-2.36) 12.7 2.53 (1.36-4.69)
0.99 (0.56-1.76) 7.3 0.79 (0.43-1.42)0
1.52 (0.95-2.46) 24.4 2.46 (1.57-3.86)
2.15 (1.53-3.01) 44.1 2.0 (1.43-2.78)
1.40 (0.89-2.20) 21.6 1.72 (1.11-2.66)











0 21.0 8.3 1.9 <0.001
1 38.8 37.7 22.9 <0.001
2 25.4 28.4 34.3 <0.051
3 7.6 16.3 23.5 <0.001
≥4 7.2 9.3 17.4 <0.001
HTN indicates hypertension.
1 Risk factors include diabetes mellitus, hypercholesterolemia (total), high LDL
and low HDL cholesterol level of blood, hypertriglyceridemia, smoking,
age> 45 years, BMI ≥25 kg/m2.
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significant association among pre-hypertensive subjects
when compared to normotensive persons. This finding
is in line with other studies [6,26,32], but contradict
Kawamoto et al. [24] findings who reported a higher
smoking rate in pre-hypertensive subjects when com-
pared with normotensive subjects.
Limitations
The two BP measurements in one day that was used for
our subject classification in the various blood pressure
categories, the higher percentage of the female popula-
tion compared to the male one, lack of data on habitual
physical activity and the absence of dietary data could be
some limitations that restricted our scientific contribution
to the area.
Conclusions
In conclusion and within the study’s limitations, over-
weight and obesity were found to be decisively asso-
ciated with the high prevalence of pre-hypertension inTable 4 Determinants of prehypertension vs normal
blood pressure from multivariable logistic regression
model
Variable OR* 95% CI p-value
Obesity 2.74 1.62-4.62 <0.001
Overweight 2.56 1.74-3.78 <0.001
Smoking 0.45 0.26-0.76 0.003
Male sex 1.89 1.27-2.81 0.002
Age (year) 0.96 0.95-0.98 <0.001
Diabetes mellitus 1.36 0.66-2.82 0.398
Total 1.07 0.56-2.03 0.833
Hypercholesterolemia
High LDL level 0.81 0.29-2.23 0.694
Low HDL level 0.92 0.63-1.32 0.65
Hypertriglyceridemia 1.28 0.78-2.12 0.326
*OR =Odds Ratio.Iranian adults. Additionally, a causative relationship
between pre-hypertension and clustering of cardiovascu-
lar risk factors was documented. Therefore, primary pre-
ventive strategies should focus on reducing overweight
and obesity if the future pre-hypertension risk in Iranian
population is to be reduced.
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